Akorn, Inc.

Shawn L. Silvestri, Ph.D. has been appointed vice president, new product development, Akorn, Inc. Dr. Silvestri brings 15 years’ experience in pharmaceutical R&D with Abbott Laboratories.

Prior to joining the company, Dr. Silvestri served as director for Abbott Diagnostics Division (ADD) focused factory and technical services from 2005 to 2007. Prior to that, he held diversified positions of increasing responsibility in pharmaceutical product and process development with Global Pharmaceutical Operations (GPO), Pharmaceutical Product Division (PPD) and Abbott International (AI). Dr. Silvestri joined Abbott as group leader, pharmaceutics and drug delivery in 1992.

Arthur S. Przybyl, president and chief executive officer, commented, “We are excited to have Shawn join our senior management team. He brings substantial new product and process development experience in specialty pharmaceuticals to Akorn and we are confident that his technical expertise and leaderships skills will be a great asset. Shawn will be responsible for transitioning our product development efforts from our manufacturing site locations to a centralized location near our corporate headquarters.”